The introduction of primary HPV screening for cervical cancer has raised concerns about the future of gynecologic cytology practice. In this presentation we will review the current FDA-approved HPV tests in the United States, how they fit into available cervical cancer screening algorithms, and how they have been adopted across the country.
- Provider:American Society of Cytopathology
- Activity Link: https://education.cytopathology.org/
- Start Date: 2022-11-22 06:00:00
- End Date: 2022-11-22 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABPATH - 2.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Cytopathology
Subscribe
Login
0 Comments
Oldest